Molecule.one grows its drug synthesis AI platform with a $4.6M seed round
TechCrunch
JUNE 1, 2021
The company’s system enters play when you have some exotic new compound you want to make in order to test it in real life, but don’t know how to make it. Polish computational chemistry outfit Molecule.one has raised $4.6M to expand its quest to bring theoretical drug molecules to reality. odarczyk-Pruszy?ski
Let's personalize your content